News Conference News AHA 2025 LAAO Doesn’t Match Medical Therapy for High-risk AF Patients: CLOSURE-AF Caitlin E. Cox November 09, 2025
News Conference News AHA 2024 OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain Todd Neale November 18, 2024
News Conference News AHA 2024 Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF Shelley Wood November 18, 2024
News Conference News AHA 2024 Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients Shelley Wood November 16, 2024
Presentation AHA 2023 The Artesia trial: Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation Presenter: Jeff Healey November 16, 2023
News Conference News AHA 2023 NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear L.A. McKeown November 12, 2023
News Conference News AHA 2023 Off-label DOAC Dosing Common in Hospitalized AF Patients, Too Todd Neale November 07, 2023
News Conference News AHA 2021 Avoiding AF Triggers Doesn’t Improve Quality of Life: I-STOP-AFib Michael O'Riordan November 14, 2021
News Conference News AHA 2020 Fish Oil, Vitamin D Don’t Prevent A-fib: VITAL Rhythm Todd Neale November 13, 2020